Acute Periprosthetic Joint Infection After Primary Total Knee Arthroplasty: Experience From a Secondary Public

Diego Emmanuel Almeida-Muñoz1, Alexis Valenzuela-González2, Ruben Cuevas-Martínez1

  • 1Research, Hospital General Dr Salvador Zubirán Anchondo, Chihuahua, MEX.

Cureus
|August 8, 2026
PubMed

Insights

This study reports a 2.0% incidence of acute periprosthetic joint infection (PJI) after total knee arthroplasty (TKA) in a Mexican hospital. It establishes a local baseline for PJI prevention and surveillance, highlighting the need for further research.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Public Health

Background:

  • Periprosthetic joint infection (PJI) is a significant complication following total knee arthroplasty (TKA).
  • Limited local data exists for PJI incidence in secondary-level public hospitals in Mexico.
  • Establishing a baseline is crucial for improving prevention and surveillance strategies.

Purpose of the Study:

  • To measure the incidence of acute PJI after primary TKA at a specific Mexican hospital.
  • To describe the characteristics of patients who developed acute PJI.
  • To establish a local baseline for PJI prevention and surveillance.

Main Methods:

  • Retrospective review of 102 primary unilateral TKA cases performed for osteoarthritis.
  • Acute PJI defined by MSIS/2018 ICM and IDSA criteria.
  • Descriptive summary of cohort characteristics and PJI incidence; detailed case descriptions for two events.

Main Results:

  • An incidence of 2.0% (95% CI: 0.5-6.9%) for acute PJI was observed (2 out of 102 patients).
  • The cohort comprised 56.9% females; common comorbidities included diabetes (24.5%) and hypertension (44.1%).
  • Both PJI cases resolved with debridement, antibiotics, and implant retention, showing no recurrence within 12 months.

Conclusions:

  • This study provides the first institutional baseline for acute knee PJI post-TKA in the analyzed setting.
  • The low event count yields an imprecise incidence estimate, precluding risk factor inference.
  • Findings support implementing guideline-based prevention, surveillance, a prospective registry, and larger multicenter studies.